Stocks
Maravai LifeSciences Holdings, Inc.MRVI
NASDAQHealthcareBiotechnology$3.08-6.38%
Price as of · delayed, not real-time
A global provider of products and services enabling the development of drug therapies, diagnostics, and novel vaccines, the company specializes in nucleic acid production and biologics safety testing. Its technologies are critical for biopharmaceutical and cell therapy companies, making it a key player in the life sciences supply chain.
Market Cap: $846.2M52W Range: $1.67 – $4.11
Congressional Interest in Maravai LifeSciences Holdings, Inc. (MRVI)
1 member of Congress has disclosed 1 trade in Maravai LifeSciences Holdings, Inc. (MRVI), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading MRVI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-10 | Daniel Goldman | sell | $1K – $15K |